A personalized blood test that can be used to spot cancer recurrence before tumor growth shows up on scans has been developed by researchers at Johns Hopkins Kimmel Cancer Center and Science Translational Medicine.

The test detects genetic rearrangements that distinguish cancer cells from normal cells. Eventually it might also pave the way for more personalized cancer treatments tailored to the genetic signature of individuals’ tumors.